Skip to main content
Clinical Trials/ISRCTN12120712
ISRCTN12120712CompletedNot Applicable

Investigation of visual acuity with near-intermediate monovision contact lens correction

Verily Life Sciences LLC (USA)0 sites130 target enrollmentStarted: July 19, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
130

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •1. Healthy and competent, as determined by the Investigator
  • •2. At least 50 years of age
  • •3. Able to read and speak English
  • •4. Able and willing to sign written Informed Consent Form
  • •5. Must be a current or former contact lens wearer
  • •6. Must have at least 20/25 distance and near vision in each eye best corrected
  • •7. Must use a presbyopic reading correction of at least +2.25 diopters
  • •8. Must have < or = 1.00D astigmatism

Exclusion Criteria

  • •1. Eye injury within 12 weeks immediately prior to enrollment for this study
  • •2. Anterior segment infection, inflammation, abnormality or any other anterior segment ocular disease that contraindicates contact lens wear as determined by the Investigator
  • •3. Any use of systemic or ocular medications for which contact lens wear could be contraindicated as determined by the Investigator
  • •4. History of herpetic keratitis
  • •5. History of refractive surgery or irregular cornea
  • •6. History of multifocal or monovision intraocular lens replacement surgery
  • •7. > 1.0mm anisocoria
  • •8. Slit lamp findings (at baseline) that are more severe than mild findings (greater than grade 2)
  • •9. Corneal vascularization greater than 1 mm of penetration
  • •10. A clinically significant dry eye determined by the Investigator
  • •11. Participation of the subject in a clinical contact lens study (including contact lens or contact lens care product) within the previous 30 days
  • •12. The Investigator, family members of the Investigator, family members of the Investigator's staff, or individuals living in the households of the aforementioned persons
  • •13. Any additional condition or situation that, in the opinion of the Investigator, makes the subject inappropriate for participation in the study

Investigators

Sponsor
Verily Life Sciences LLC (USA)

Similar Trials